As of Oct 12, 2026 close
- Market cap
- $529.83M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.41$8.21
- Volume (live)
- -
- Avg. volume (3M)
- 3.99M
CytomX Therapeutics (CTMX) Stock Price & Financial Analysis
CytomX Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.44 - $2.58 |
|---|---|
| 52-Week High | $8.21 |
| 52-Week Low | $2.41 |
| Open | $2.46 |
| Volume (last close) | 3.04M |
| Average Volume (3M) | 3.99M |
| Market Cap | 529.83M |
|---|---|
| Shares Outstanding | 218.94M |
| Price to Sales (P/S) | 28.95 |
| Price to Book (P/B) | 1.75 |
| EV/EBITDA | -6.12 |
| Revenue (TTM) | 18.30M |
|---|---|
| Net Income (TTM) | -79.65M |
| Free Cash Flow (TTM) | -82.48M |
| EPS (TTM) | $-0.44 |
| Profit Margin | -435.21% |
| Operating Margin | -476.19% |
| Return on Equity (ROE) | -26.37% |
| Debt to Equity | 0.02 |
| 50-Day MA | $3.12 |
|---|---|
| 200-Day MA | $4.01 |
| 1-Year Change | −28.82% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
CytomX Therapeutics at a Glance
CytomX Therapeutics (CTMX) has a market capitalization of $529.83M. The stock trades at 28.9× sales. Over the trailing twelve months it lost $79.65M on revenue of $18.30M and burned $82.48M of free cash flow. Revenue fell 87.0% year over year.
It holds $17.22M in cash and securities against $5.70M of debt, a net cash position of $11.52M.
CytomX Therapeutics does not currently pay a dividend.
The share price is down 28.8% over the past year. At $2.42 it sits near the bottom of its 52-week range of $2.41 to $8.21, below its 200-day moving average of $4.01.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.25, 447.5% above the latest close.
Frequently Asked Questions About CytomX Therapeutics
What is the current stock price for CTMX?
As of the Oct 9, 2026 close, CTMX stock trades at $2.57. The 52-week range is $2.41–$8.21, with a day range of $2.44–$2.58.
What is the P/E ratio for CTMX?
The P/E ratio (Price-to-Earnings) for CTMX is shown in the Key Statistics section. This valuation metric helps compare CytomX Therapeutics, Inc. to industry peers.
Does CTMX pay dividends?
CytomX Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTMX?
Based on 4 analysts, the consensus for CTMX is Buy.
What is the market cap of CTMX?
CytomX Therapeutics's market capitalization is $562.7M, classifying it as a small-cap company. CytomX Therapeutics operates in the Healthcare sector within the Biotechnology industry.